Strain CR326F of hepatitis A virus, derived from a fecal specimen of Costa Rican patient 033-03, was passed 15 times in fetal rhesus monkey kidney (FRhK6) cell cultures plus eight times in human diploid lung (MRC5) cell cultures to yield variant F and 16 times in MRC5 cell cultures to yield variant
Further evaluation of a live hepatitis A vaccine in marmosets
β Scribed by P. J. Provost; F. S. Banker; C. W. Wadsworth; D. L. Krah
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 538 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Live, attenuated FΜ hepatitis virus was studied in vivo in Saguinus labiatus marmosets for possible reversion to virulence, for possible establishment of persistent infection and for its capacity as a parenterally administered vaccine to induce immunity to oral infection. Serial transmission of the virus in S. labiatus, using infectious stool extracts for the second and third passages, produced no evidence of reversion of the FΜ vaccine virus to virulence. Monitoring for live HAV in stools over a 135βday period postinoculation of marmosets with the Fβ² vaccine revealed no evidence of persistent infection. Vaccinated animals were also shown to be resistant to infection on challenge by the oral route as well as by the previously demonstrated parenteral route.
π SIMILAR VOLUMES
In the 1981 study, Helmuth found that the futures price dropped within a short period of time when the live cattle futures price equaled or exceeded the USDA reported Corn Belt cost of feeding plus a Midwestern basis adjustment (Staff, 1981). Simulated trading with this indicator was successful all
## Abstract The chimeric flavivirus LGT/DEN4 containing prM and E genes of naturally attenuated Langat virus with remaining sequence derived from low neuroinvasive Dengue 4 virus was previously produced and assessed as a candidate for live vaccine against tickβborne encephalitis (TBE) [Pletnev and
## Abstract A multicentre, controlled, randomised, open, comparative trial including 839 healthy adult volunteers was carried out in order to compare the immunogenicity and reactogenicity of two vaccines against hepatitis A virus (HAV) during primary immunization and after booster injection. The fi